@Injective is a Layer-1 blockchain built for finance, offering high throughput, sub-second finality, and low fees. Launched in 2018, it bridges global finance on-chain with interoperability across Ethereum, Solana, and Cosmos. Its modular architecture simplifies development, while INJ powers transactions, staking, and governance, driving a secure, scalable DeFi ecosystem.
✅ What is Injective (INJ)?
Injective is the native token of the Injective Protocol — a blockchain/DeFi infrastructure project that focuses on decentralized trading (especially derivatives, futures, prediction markets), spot trading, cross-chain interoperability, and generally building DeFi “markets” rather than simple token swaps.
The protocol: Built using the Cosmos SDK (so somewhat “Layer 1” or “application chain” style) and aims to allow users to create and trade any kind of market (spot, derivatives, prediction) in a fully decentralized way.
Use-cases: The INJ token is used for governance (voting on protocol decisions), staking (securing the network), fee payments in some cases, protocol incentives/liquidity mining.
📊 Key Metrics & Tokenomics
Circulating supply: ~99 – 100 million INJ.
Total/Max supply: ~100 million INJ (sources show total supply = 100 M).
Market Cap: Roughly around US$700–800 million (as of this writing) depending on price and source.
Price: One token is about US$7-8 (again depending on exchange/time) at the moment.
All‐Time High (ATH): INJ peaked significantly higher (above US$50 in some data).
🔍 What drives INJ’s value (factors)
Demand-side factors
Protocol usage/adoption: The more the Injective Protocol network is used (trading volumes, derivatives markets, prediction markets, cross-chain activity), the more requirement or value for INJ (via fees, staking, governance).
Staking / token utility: If INJ is required or beneficial to stake (for rewards or governance) then that creates demand for token holders.
Ecosystem growth & partnerships: New integrations,
